
Scegli la tua etichetta
mostrata direttamente sul flaconcinoReferto di laboratorio
PDF- Testato
- SLU-PP-332 Oral 5mg × 100 Tabs
- Laboratorio
- Analiza Białek
- Data
- August 2026
- Risultato
- 5.12 mg per tablet (5 mg label)
- N. ordine
- Password
Testato in modo indipendente, verificabile con la password direttamente presso il laboratorio.
SLU-PP-332 Oral
Anti-Aging Oral
- Testato in laboratorio
- Spedito dalla Germania
Ordine
- DHL con tracciamento
- Imballaggio discreto
In sintesi
SLU-PP-332 Oral in cifre
I dati chiave dalla nostra enciclopedia.
Voce completa dell'enciclopedia- Class
- ERR agonistexercise mimetic
- Frequency
- Dailyrather in the morning
- Sizes
- 7 sizes250mcg*100tabs, 500mcg*100tabs, 1mg*100tabs …
What studies show
The source in the lexiconSynthetic ERR agonist alleviates metabolic syndrome (mouse model, preclinical) (opens in a new tab)
Billon et al., J. of Pharmacology and Experimental Therapeutics, 2024
Recensioni
Cosa dicono i clienti
Solo ordini reali che includevano SLU-PP-332 Oral.
Tutte le recensioniConoscenze
Tutto su SLU-PP-332 Oral
Informazioni dettagliate in arrivo.
Are there studies in humans?
No. As of 26 October 2026 ClinicalTrials.gov lists no trial with SLU-PP-332 and ChEMBL lists it without a clinical phase. All data come from cell assays and mouse models.
What does SLU-PP-332 do in the cell?
It activates the three nuclear receptors ERRα, ERRβ and ERRγ, most strongly ERRα. These receptors switch on genes for mitochondria and fat burning. In muscle cells mitochondrial function and cellular respiration rose.
What did the mouse studies show?
Sedentary mice ran about 70 percent longer and 45 percent further after 7 days, the share of endurance muscle fibres rose. In obese mice energy use and fat burning rose, fat mass increased less and insulin action improved.
Does it work as a tablet too?
That has not been studied. In the endurance study SLU-PP-332 was injected into the abdominal cavity, two hours later its level was higher in muscle than in blood. There are no data on oral absorption in humans.
What about heart and kidney?
In a mouse model of pressure-overload heart failure SLU-PP-332 improved pumping function, reduced fibrosis and extended survival, mainly via ERRγ. In 21-month-old mice protein loss in urine and inflammation in the kidney fell after 8 weeks.
Which side effects are known?
There are no solid data because SLU-PP-332 has never been tested in humans. In mice no obvious toxicity appeared over 10 days. That does not rule out risks in humans.
Correlati
Prodotti correlati
SLU-PP-332 Oral